Inhibition of CDK9 attenuates atherosclerosis by inhibiting inflammation and phenotypic switching of vascular smooth muscle cells (vol 13, pg 14892, 2021)

被引：0

作者：

Huang, Shushi ^{[1
,2
]}

Luo, Wu ^{[1
,3
]}

Wu, Gaojun ^{[2
]}

Shen, Qirui ^{[1
]}

Zhuang, Zaishou ^{[3
]}

Yang, Daona ^{[3
]}

Qian, Jinfu ^{[1
]}

Hu, Xiang ^{[4
]}

Cai, Yan ^{[3
]}

Chattipakorn, Nipon ^{[5
]}

Huang, Weijian ^{[2
]}

Liang, Guang ^{[1
,3
,6
]}

机构：

[1] Wenzhou Med Univ, Chem Biol Res Ctr, Sch Pharmaceut Sci, Wenzhou 325035, Zhejiang, Peoples R China

[2] Wenzhou Med Univ, Affiliated Hosp 1, Dept Cardiol, Wenzhou 325035, Zhejiang, Peoples R China

[3] Wenzhou Med Univ, Affiliated Cangnan Hosp, Cangnan 325000, Zhejiang, Peoples R China

[4] Wenzhou Med Univ, Affiliated Hosp 1, Dept Endocrinol, Wenzhou 325035, Zhejiang, Peoples R China

[5] Chiang Mai Univ, Fac Med, Cardiac Electrophysiol Res & Training Ctr, Chiang Mai 50200, Thailand

[6] Hangzhou Med Coll, Sch Pharmaceut Sci, Hangzhou 311399, Zhejiang, Peoples R China

来源：

AGING-US | 2022年 / 14卷 / 07期

关键词：

atherosclerosis; CDK9; pharmacological inhibition; inflammation; phenotypic switching; vascular smooth muscle cells;

D O I：

暂无

中图分类号：

Q2 [细胞生物学];

学科分类号：

071009 ; 090102 ;

摘要：

引用

页码：3329 / 3330

页数：2